Skip to Main content Skip to Navigation
Journal articles

Epigenome-wide DNA methylation profiling in Progressive Supranuclear Palsy reveals major changes at DLX1

Abstract : Genetic, epigenetic, and environmental factors contribute to the multifactorial disorder progressive supranuclear palsy (PSP). Here, we study epigenetic changes by genome-wide analysis of DNA from postmortem tissue of forebrains of patients and controls and detect significant (P < 0.05) methylation differences at 717 CpG sites in PSP vs. controls. Four-hundred fifty-one of these sites are associated with protein-coding genes. While differential methylation only affects a few sites in most genes, DLX1 is hypermethylated at multiple sites. Expression of an antisense transcript of DLX1, DLX1AS, is reduced in PSP brains. The amount of DLX1 protein is increased in gray matter of PSP forebrains. Pathway analysis suggests that DLX1 influences MAPT-encoded Tau protein. In a cell system, overexpression of DLX1 results in downregulation of MAPT while overexpression of DLX1AS causes upregulation of MAPT. Our observations suggest that altered DLX1 methylation and expression contribute to pathogenesis of PSP by influencing MAPT
Document type :
Journal articles
Complete list of metadatas

https://hal-cea.archives-ouvertes.fr/cea-01877684
Contributor : Bruno Savelli <>
Submitted on : Thursday, September 20, 2018 - 11:18:29 AM
Last modification on : Monday, May 18, 2020 - 12:24:06 PM

Links full text

Identifiers

Collections

Citation

Axel Weber, Sigrid Schwarz, Jorg Tost, Dietrich Trümbach, Pia Winter, et al.. Epigenome-wide DNA methylation profiling in Progressive Supranuclear Palsy reveals major changes at DLX1. Nature Communications, Nature Publishing Group, 2018, 9, pp.2929. ⟨10.1038/s41467-018-05325-y⟩. ⟨cea-01877684⟩

Share

Metrics

Record views

129